Skip to content

JAZZJAZZ PHARMACEUTICALS PLC

CUSIP G50871105 · common stock

3 tracked investors held JAZZ PHARMACEUTICALS PLC (JAZZ) at the end of Q3 2026, worth $56.6M in total. The largest holder was Joel Greenblatt, with 0.1% of its portfolio. Perceptive Advisors sold out of its position this quarter.

Holders · Q3 2026
3
New holders
0
Value held
$56.6M
Quarter-end price (est.)
$231.52

Investors holding JAZZ · Q3 2026

InvestorWeightSharesValueChange
Joel Greenblatt
Gotham Asset Management, LLC
0.08%182,858$42.3MADD+63.2%
Tweedy Browne
Tweedy, Browne Co LLC
1.12%59,279$13.7MREDUCE-1.4%
Polen Capital Management
Polen Capital Management LLC
0.01%2,125$492KADD+14.4%

Sold out this quarter

InvestorPrior weightPrior sharesPrior valueChange
Perceptive Advisors0.61%170,000$41MEXIT

History

QuarterHoldersNewSold outValue heldQuarter-end price (est.)
Q3 2026301$56.6M$231.52
Q2 2026411$82.9M$240.97
Q1 2026410$61.4M$189.05
Q4 2025300$40.7M$170.00
Q3 2024001$0—
Q2 2024100$136M$106.73
Q1 2024100$100.4M$120.42
Q4 2023100$102.5M$123.00
Q3 2023100$87.2M$129.44
Q2 2023100$83.5M$123.97
Q1 2023110$70M$146.33